Table 3.

Effects of Combinations of Five Cytokines on the Maintenance and Expansion of Freshly Purified Human Fetal BM CD34+ thy-1+ Cells In Vitro

Treatments Frequency of CD34+thy-1+/ Positive Wells Percentage of CD34+ thy-1+ Cells
Control  0% (0/300) NA  
IL-3  0% (0/300)  NA  
IL-6  0% (0/300) NA  
GM-CSF  0% (0/300)  NA  
SCF  0% (0/300) NA  
LIF  10% (30/300)   7 ± 1 
LIF + IL-3 + IL-6  11% (32/300)  15 ± 2 
LIF + IL-3 + IL-6 + GM-CSF  10% (30/300)  15 ± 2 
LIF + IL-3 + IL-6 + GM-CSF + SCF  12% (35/300) 15 ± 1 
Treatments Frequency of CD34+thy-1+/ Positive Wells Percentage of CD34+ thy-1+ Cells
Control  0% (0/300) NA  
IL-3  0% (0/300)  NA  
IL-6  0% (0/300) NA  
GM-CSF  0% (0/300)  NA  
SCF  0% (0/300) NA  
LIF  10% (30/300)   7 ± 1 
LIF + IL-3 + IL-6  11% (32/300)  15 ± 2 
LIF + IL-3 + IL-6 + GM-CSF  10% (30/300)  15 ± 2 
LIF + IL-3 + IL-6 + GM-CSF + SCF  12% (35/300) 15 ± 1 

A well is scored as CD34+ thy-1+/positive only if it has >1% of CD34+ thy-1+ cells in the well. Numbers in parentheses indicate the total number of CD34+ thy-1+/positive wells divided by the total number of wells analyzed in the experiments. Data for the percentage of CD34+ thy-1+ cells in the CD34+ thy-1+/positive wells are presented as the mean ± SD of the total number of CD34+thy-1+/positive wells in each culture condition.

Abbreviation: NA, not applicable.